![Elizabeth O'Farrell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth O'Farrell
Chairman at
GERON CORPORATION
Net worth: 934 312 $ as of 2026-05-30
Profile
Elizabeth G.
O'Farrell is Chairman at Geron Corp.
since 2025.
Ms. O'Farrell is Chairman at PDL BioPharma, Inc. since 2020.
Ms. O'Farrell is Independent Director at LENSAR, Inc. since 2021.
Ms. O'Farrell is Independent Director at SpyGlass Pharma, Inc. since 2025.
Ms. O'Farrell is Independent Director at Genmab A since 2022.
Ms. O'Farrell is Director at Karius, Inc. since 2023.
Former roles include Chief Financial Officer & Executive Director at Eli Lilly Canada, Inc., Director at Washington Township Schools Foundation from 2003 to 2010, Independent Director at Inhibikase Therapeutics, Inc. from 2019 to 2022, Director at Keep Indianapolis Beautiful, Inc., Director at Y.M.C.A. Foundation of Greater Indianapolis from 2016 to 2017, Chief Procurement Officer at Eli Lilly & Co. from 2012 to 2017, Accountant at OfficeMax Contract, Inc., Auditor at Pricewaterhouse LLP, Auditor at Whipple & Co., Manager at Somerset Financial Services LLC, and Chief Financial Officer, SVP-Policy & Finance at Lilly USA LLC.
Education includes an MBA degree conferred in 1987 and an undergraduate degree conferred in 1986, both from Indiana University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-16 | 1,885 ( 0% ) | 501 544 $ | 2026-05-30 | |
LENSAR INC 0.56% | 2026-06-02 | 67,368 ( 0.56% ) | 390 734 $ | 2026-05-30 |
GERON CORPORATION 0.01% | 2026-05-19 | 33,627 ( 0.01% ) | 42 034 $ | 2026-05-30 |
| 2026-02-04 | 0 ( -.--% ) | - $ | 2026-05-30 |
Elizabeth O'Farrell active positions
| Companies | Position | Start |
|---|---|---|
| PDL BIOPHARMA, INC. | Chairman | 2019-12-31 |
| GERON CORPORATION | Chairman | 2025-03-11 |
| LENSAR, INC. | Director/Board Member | 2021-01-31 |
| GENMAB A/S | Director/Board Member | 2022-03-28 |
| SPYGLASS PHARMA, INC. | Director/Board Member | 2025-07-31 |
Karius, Inc.
 Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Director/Board Member | 2023-08-09 |
Former positions of Elizabeth O'Farrell
| Companies | Position | End |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Director/Board Member | 2022-08-31 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2017-11-30 |
Y.M.C.A. Foundation of Greater Indianapolis
 Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Chairman | 2016-12-31 |
| ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Elizabeth O'Farrell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
OfficeMax Contract, Inc.
 OfficeMax Contract, Inc. Forest ProductsNon-Energy Minerals Makes paper, office and building products | Non-Energy Minerals |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
LENSAR, Inc.
 LENSAR, Inc. Medical SpecialtiesHealth Technology Develops femtosecond laser technologies for refractive cataract surgery | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Pricewaterhouse LLP
 Pricewaterhouse LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Eli Lilly Canada, Inc.
 Eli Lilly Canada, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, drugs, chemicals | Health Technology |
Whipple & Co.
 Whipple & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Somerset Financial Services LLC
 Somerset Financial Services LLC Investment ManagersFinance Provides financial services | Finance |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Washington Township Schools Foundation | |
Lilly USA LLC
 Lilly USA LLC Pharmaceuticals: MajorHealth Technology Lilly USA LLC engages in the provision of pharmaceutical services. The company was founded on July 15, 2008 and is headquartered in Indianapolis, IN. | Health Technology |
Y.M.C.A. Foundation of Greater Indianapolis
Y.M.C.A. Foundation of Greater Indianapolis Miscellaneous Commercial ServicesCommercial Services Provides wellness programs | Commercial Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Karius, Inc.
Karius, Inc. Medical/Nursing ServicesHealth Services Operates as clinical and medical research laboratory to improve the diagnosis & treatment of infectious diseases for hospitals and physicians | Health Services |
Keep Indianapolis Beautiful, Inc.
 Keep Indianapolis Beautiful, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as an environmental and community non-profit organization | Commercial Services |
SpyGlass Pharma Inc
 SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
- Stock Market
- Insiders
- Elizabeth O'Farrell
